Bank Of America Corp 9 Meters Biopharma, Inc. Transaction History

Bank Of America Corp

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$0.21 - $0.32 $11,819 - $18,010	56,284 Added 113.72%	105,778 $23,000
Q2 2022 Aug 12, 2022	BUY	$0.26 - $0.64 $1,844 - $4,540	7,094 Added 16.73%	49,494 $12,000
Q1 2022 May 16, 2022	SELL	$0.52 - $1.0 $39,104 - $75,200	-75,200 Reduced 63.95%	42,400 $25,000
Q4 2021 Feb 08, 2022	BUY	$0.85 - $1.33 $62,351 - $97,562	73,355 Added 165.79%	117,600 $114,000
Q3 2021 Nov 15, 2021	SELL	$1.03 - $1.41 $135,918 - $186,063	-131,960 Reduced 74.89%	44,245 $57,000
Q2 2021 Sep 13, 2021	BUY	$1.04 - $1.5 $183,253 - $264,307	176,205 New	176,205 $194,000

67.9K

Ticker NMTR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 12,955,400
Market Cap $259K
Description
9 Meters Biopharma, Inc., a clinical-stage biopharmaceutical company, focuses on treatments for people with rare digestive diseases, gastrointestinal conditions with unmet needs, and debilitating disorders. The company is developing Larazotide, an 8-amino acid peptide, which is in Phase 3 clinical trial for the treatment of celiac disease, as we...

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

Stay updated on Bank Of America Corp with notifications on news.